Informatie:
Fout:
ID
17688
Beschrijving
Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL); ODM derived from: https://clinicaltrials.gov/show/NCT00237588
Link
https://clinicaltrials.gov/show/NCT00237588
Trefwoorden
Versies (1)
- 28-09-16 28-09-16 -
Geüploaded op
28 september 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hypertension NCT00237588
Eligibility Hypertension NCT00237588
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT00237588
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Essential Hypertension | Diastolic blood pressure | Systolic Pressure
Item
essential hypertension with diastolic blood pressure 95-110 mmhg and systolic blood pressure < 180 mmhg
boolean
C0085580 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0871470 (UMLS CUI [3])
C0428883 (UMLS CUI [2])
C0871470 (UMLS CUI [3])
hypertension untreated | Therapeutic procedure Hypertensive disease | Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
previously untreated hypertension or treated with monotherapy (but not with ace-inhibitors or angiotensin ii-receptor blockers)
boolean
C0745134 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0020538 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
C0087111 (UMLS CUI [2,1])
C0020538 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
Impaired glucose tolerance | Impaired fasting glycaemia | Plasma fasting glucose measurement
Item
impaired glucose tolerance or impaired fasting glucose (fasting plasma glucose; 6.1-7.0 mmol/l (110-126 mg/dl)
boolean
C0271650 (UMLS CUI [1])
C1272092 (UMLS CUI [2])
C0583513 (UMLS CUI [3])
C1272092 (UMLS CUI [2])
C0583513 (UMLS CUI [3])
Age
Item
age over 18
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Microalbuminuria | Dyslipidemias | Serum HDL cholesterol measurement | Triglycerides measurement | Waist-Hip Ratio | Gender | Body mass index
Item
any one of these: microalbuminuria (urin excretion >20 microg/min), dyslipidemia (hdl-cholesterol <0.9 mmol/l(35 mg/dl), triglycerides > 1.7 mmol/l (150 mg/dl), waist to hip-ratio >0.9 in men and >0.85 in women, bmi >28 kg/m2.
boolean
C0730345 (UMLS CUI [1])
C0242339 (UMLS CUI [2])
C0428472 (UMLS CUI [3])
C0202236 (UMLS CUI [4])
C0205682 (UMLS CUI [5])
C0079399 (UMLS CUI [6])
C1305855 (UMLS CUI [7])
C0242339 (UMLS CUI [2])
C0428472 (UMLS CUI [3])
C0202236 (UMLS CUI [4])
C0205682 (UMLS CUI [5])
C0079399 (UMLS CUI [6])
C1305855 (UMLS CUI [7])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
previous or current use of ace-inhibitors or angiotensin ii-receptor blockers
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
Antidiabetics
Item
previous or current antidiabetic medications
boolean
C0935929 (UMLS CUI [1])
Prediabetes syndrome | Pharmacotherapy Anticipated
Item
"brittle" pre-diabetes where the investigator anticipates pharmacological treatment within next 6 months
boolean
C0362046 (UMLS CUI [1])
C0013216 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
C0013216 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
Hypertensive | Combination Drug Therapy Anticipated
Item
hypertensive patients where the investigator anticipates polytherapy within next 6 months
boolean
C0857121 (UMLS CUI [1])
C0013218 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
C0013218 (UMLS CUI [2,1])
C3840775 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
female patient who is pregnant or nursing or planning pregnancy within the duration of the study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])